The week in review
As the countdown nears to the 1 September D-Day, attention in pharmacy continues to centre around 60-day dispensing The week began with Opposition Health spokesperson Senator Anne Ruston warning again …
Criminal standard under review
Regulator calls for public consultation on criminal history standard for registered health practitioners Australia’s health practitioner regulator is inviting the public to contribute towards its review of the national standard …
Steering an uncharted course for pharmacy
Lisa Nguyen stepped into uncharted territory when she founded Australia’s first cannabis-specialised dispensary. She talks about what drew her to specialise in this area, and the hot topics It’s one …
Transforming pharmacy
SHPA President Tom Simpson talks about the organisation’s new Transformation agenda for pharmacy This week SHPA released Transformation 2024, a ‘growth agenda over the next twelve months to expand the …
Tightening the screws
TGA says it will clamp down on vapes, medicinal cannabis and the wellness industry over the next 12 months The Therapeutic Goods Administration (TGA) has published its import, advertising and supply …
Looking at harm minimisation
Naloxone, hazardous use of alcohol and treatment inequity: part two of our expert discussion of the latest in harm minimisation Why is the naloxone program not seeing wider take-up? Should …
July MIMS update
We look at some of the recent changes to the medicines landscape, with new products, new indications, safety related changes and more New Products Finerenone (Kerendia) is a nonsteroidal antagonist …
Top 10: Dispensing dominates agenda
Double dispensing dominates our list of the top ten best read stories over the the previous month Eight of the ten most read stories on our website over the previous …
Overstepping the boundaries
Notifications of health practitioner boundary violations have jumped by almost 50% in two years, Ahpra says There has been a “sustained jump” in the reporting of boundary violations by healthcare …
Keeping up with the business
We reveal the 10 most read columns from our business experts so far this year While 60 day dispensing again features prominently in one of our half yearly top story …
Hospital concerns met
SHPA welcomes support for post-discharge medicine supply and the successful trial of a new liquid opioid management system A major New South Wales government announcement meets long-standing requests for post-discharge …
Looking at harm minimisation
Methadone, buprenorphine, drug testing, naloxone and more: we discuss the latest views and opinions with a panel of experts Why is the naloxone program not seeing wider take-up? Should pharmacists …